News | August 23, 2017

Unum Therapeutics Announces Active Investigational New Drug (IND) Application for ACTR087 in Combination with SEA-BCMA in Patients with Relapsed/Refractory Multiple Myeloma – First ACTR Combination Therapy Under Unum’s Collaboration with Seattle Genetics –...

News | July 13, 2017

Baylor Scott & White Health Selects Kyruus’ Solutions to Enhance Provider Data Management and Patient Access Leading Texas Health System to Leverage the KyruusOne™ Platform and ProviderMatch APIs to Create a Comprehensive Provider Directory and Improve Access to...

News | February 17, 2017

Mercy Health and Kyruus Forge Strategic Partnership to Further Enterprise-Wide Patient Access by Kyruus, on Feb 17, 2017 9:20:00 AM BOSTON, MA – Kyruus, a leader in provider search and scheduling solutions for health systems, announced today that Mercy Health (based...

News | February 17, 2017

Arvinas Presents New Preclinical Data on Oral Androgen Receptor PROTAC at ASCO 2017 Genitourinary Cancers Symposium Data shows robust degradation of androgen receptor in vitro and in vivo NEW HAVEN, Conn., February 17, 2017 – Arvinas LLC, a private biotechnology...

News | February 3, 2017

Intarcia Announces FDA Filing Acceptance of New Drug Application (NDA) for ITCA 650 for the Treatment of Type 2 Diabetes Boston, MA – February 3, 2017 – Intarcia Therapeutics, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for...

News | January 5, 2017

Arvinas Appoints Dr. John Houston as President of Research and Development and Chief Scientific Officer NEW HAVEN, Conn., January 5, 2017 – Arvinas LLC, a private biotechnology company creating a new class of drugs based on protein degradation, today announced that it...